Coamorphization of
a poorly water-soluble active pharmaceutical
ingredient (API) has been proven to be effective in improving its
solubility. Generally, API can form multiple coamorphous systems with
different coformers. However, it remains unclear how the pK
a value of different coformers influences the
solubility of the API. In this study, structurally related cinnamic
acid (CA, pK
a = 4.37) and p-hydroxycinnamic acid (pHCA, pK
a = 4.65)
were chosen as coformers for the coamorphization of lurasidone hydrochloride
(LH). To investigate the influence of the pK
a value of the coformers on the solubility of LH, LH-CA/pHCA
coamorphous systems were prepared by the vacuum rotary evaporation
method and characterized by powder X-ray diffraction and differential
scanning calorimetry. Fourier-transform infrared spectroscopy, Raman
spectroscopy, and molecular dynamics (MD) simulations were employed
to investigate the intermolecular interaction of the coamorphous systems.
It was found that the solubility of LH in the coamorphous LH–pHAC with a higher-pK
a coformer
was higher than that of the coamorphous LH-CA. In addition, according
to the solubility product principle-based formula derivation, we established
the functional relationship between the solubility of LH and the pK
a of the coformers at different-pH buffering
solution. It was found that the coformer with a larger pK
a value would be more beneficial to improve the solubility
profile of LH. Collectively, the current study offers an effective
strategy to improve the poor solubility of drugs by increasing the
pK
a value of the coformer in coamorphous
systems.